Abstract
Diabetes mellitus, better known simply as "diabetes", is a chronic disease that occurs when elevated blood glucose levels occur because the body stops producing or does not produce enough of the hormone called insulin, or fails use said hormone effectively. Currently 6.4 million Mexicans have a medical diagnosis of DM II, that is, 9.4% of the adult population (20 years and older). However, this figure does not include those who have not been diagnosed or are at high risk of developing the disease. DM II is the second cause of death in Mexico and is among the five leading causes of years of life lived with disabilities. Objective: Evaluate the Cost Effectiveness of Diabetes treatment in Mexico. Material and Method: A systematic review was carried out on the Internet based on articles published in Crossref, PUBMED, JCR, NCBI, SCOPUS, information from government institutions; the search is performed using keywords such as; Cost-Effectiveness and Diabetes. Results: Of a total of 22 references reviewed, 5. (23%) were detected in CROSSREF, 12 (54%) in PUBMED, 5 (23%) were detected from information from government institutions. Conclusion: According to the revised literature, the expense that is made in Mexico for diabetes care is high, but most of that investment is going to treat complications and not prevention.
Publisher
Universidad Autonoma del Estado de Hidalgo
Subject
General Earth and Planetary Sciences
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献